Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

9
Number of overlapping holdings
13.8%
% of XLV's 65 holdings also in XPH
24.3%
% of XPH's 40 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 9.2% | 5.6% | 5.6% | |
MERCK & CO. INC. | 5.5% | 4.2% | 4.2% | |
JOHNSON & JOHNSON | 7.9% | 4.0% | 4.0% | |
PFIZER INC | 3.9% | 3.8% | 3.8% | |
BRISTOL-MYERS SQUIBB CO | 2.5% | 3.9% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XPH
UNITEDHEALTH GROUP INC | 9.2% | |
ABBVIE INC | 5.4% | |
THERMO FISHER SCIENTIFIC INC | 4.0% | |
JOHNSON & JOHNSON | 3.9% | |
ELI LILLY & CO | 3.6% | |
ABBOTT LABORATORIES | 3.6% | |
DANAHER CORP | 3.4% | |
AMGEN INC | 2.8% | |
MEDTRONIC PLC | 2.2% | |
ANTHEM INC | 2.1% |
XLV Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% | |
ELANCO ANIMAL HEALTH, INC. | -5.7% | |
CATALENT INC | -5.3% | |
JAZZ PHARMACEUTICALS PLC | -4.5% | |
AXSOME THERAPEUTICS, INC. | -4.4% | |
VIATRIS, INC. | -4.3% | |
ORGANON & CO. | -3.7% | |
PERRIGO CO | -3.7% | |
ROYALTY PHARMA PLC CLASS A | -3.7% | |
INTRA-CELLULAR THERAPIES INC | -3.6% |